ARTELO (ARTL) Director Kelly Steven Receives 136-Share Award

What Happened

• Kelly Steven, a director of ARTELO BIOSCIENCES, INC. (ARTL), was granted 136 shares on July 17, 2026. The shares were acquired at $0.00 (derivative award, transaction code A), meaning no cash was paid.
• This is a grant/award (not a purchase or sale). The award is subject to vesting and contingent on continued service to the company.

Key Details

• Transaction date: 2026-07-17; Filing date: 2026-07-21 (Form 4 filed within the required reporting window).
• Shares granted: 136 shares; Price paid: $0.00; Transaction type: Award/Grant (derivative).
• Shares owned after the transaction: not specified in the provided filing details.
• Footnote: Vesting is contingent on the Reporting Person remaining a “Service Provider.” 100% of the shares will vest on the earlier of (i) the one-year anniversary of the Vesting Commencement Date or (ii) the day prior to the date of the issuer’s next annual meeting. The Vesting Commencement Date is July 17, 2026.

Context

• This appears to be a standard director equity award (restricted shares or similar) with a one-year cliff vesting tied to continued service — a common form of non-cash director compensation. Such grants do not necessarily indicate immediate buying or selling intent.